We are live on ! Find out more
RVNC

Revance Therapeutics, Inc.
RVNC

Delisted

RVNC was delisted on the 5th of February, 2025.

Back to rankings

151 hedge funds and large institutions have $827M invested in Revance Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 56 increasing their positions, 41 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 41

20% more call options, than puts

Call options by funds: $11.7M | Put options by funds: $9.78M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 37

4% less funds holding

Funds holding: 158 → 151 (-7)

44% less capital invested

Capital invested by funds: $1.48B → $827M (-$650M)

Holders
151
Holders Change
-7
Holders Change %
-4.43%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
34
Increased
56
Reduced
41
Closed
37
Calls
$11.7M
Puts
$9.78M
Net Calls
+$1.96M
Net Calls Change
+$5.27M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$30.7M
2
HM
HealthCor Management
New York
+$22.8M
3
PAI
Palo Alto Investors
California
+$19.5M
4
Capital World Investors
Capital World Investors
California
+$12.4M
5
PCH
Polar Capital Holdings
United Kingdom
+$8.61M

Top Sellers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
-$78.2M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$52.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$25.2M
4
Principal Financial Group
Principal Financial Group
Iowa
-$11.5M
5
DCM
Driehaus Capital Management
Illinois
-$10.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
76
DekaBank Deutsche Girozentrale
Germany
$468K -$657K -39,400 -58%
VOYA Investment Management
77
VOYA Investment Management
Georgia
$453K +$5.45K +327 +1%
MIM
78
MetLife Investment Management
New Jersey
$415K – – –
ProShare Advisors
79
ProShare Advisors
Maryland
$414K +$18.1K +1,085 +4%
Lazard Asset Management
80
Lazard Asset Management
New York
$408K +$418K +25,048 New
Commonwealth Equity Services
81
Commonwealth Equity Services
Massachusetts
$403K +$59.3K +3,555 +17%
State Board of Administration of Florida Retirement System
82
State Board of Administration of Florida Retirement System
Florida
$387K +$2.62K +157 +0.7%
CF
83
Centaurus Financial
California
$341K -$506K -30,342 -59%
Mercer Global Advisors
84
Mercer Global Advisors
Colorado
$334K -$51.5K -3,087 -13%
AI
85
Accredited Investors
Minnesota
$334K – – –
Envestnet Asset Management
86
Envestnet Asset Management
Illinois
$331K -$253K -15,197 -43%
TRSOTSOK
87
Teachers Retirement System of the State of Kentucky
Kentucky
$331K – – –
ASRS
88
Arizona State Retirement System
Arizona
$300K -$2.4K -144 -0.8%
MLICM
89
Metropolitan Life Insurance Company (MetLife)
New York
$277K -$45K -2,700 -14%
Handelsbanken Fonder
90
Handelsbanken Fonder
Sweden
$263K – – –
BNP Paribas Financial Markets
91
BNP Paribas Financial Markets
France
$261K -$20.1K -1,203 -7%
BAM
92
Blueshift Asset Management
New Jersey
$257K +$262K +15,722 New
FAM
93
Flaharty Asset Management
Florida
$252K +$258K +15,452 New
II
94
Inspire Investing
Idaho
$251K +$257K +15,407 New
Public Employees Retirement Association of Colorado
95
Public Employees Retirement Association of Colorado
Colorado
$249K – – –
Rafferty Asset Management
96
Rafferty Asset Management
New York
$240K +$115K +6,923 +89%
Janus Henderson Group
97
Janus Henderson Group
United Kingdom
$225K +$230K +13,784 New
NA
98
Nottingham Advisors
New York
$217K – – –
Ensign Peak Advisors
99
Ensign Peak Advisors
Utah
$216K +$221K +13,230 New
PWP
100
Perfromance Wealth Partners
Illinois
$212K +$217K +13,000 New
2 3
4
5 6

RVNC Hedge Fund Activity: Q4 2021 in Review

151 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Revance Therapeutics, Inc. (RVNC) for Q4 2021, worth a combined $827M — down 44% from $1.48B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of RVNC and 34 opened new positions — a net loss of 3 holders — while 41 trimmed existing stakes and 56 added.

The largest buyer was JP Morgan Chase, adding an estimated $30.7M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $78.2M sold.

  • 151 institutional investors held Revance Therapeutics, Inc. (RVNC) as of Q4 2021, down from 158 in Q3 2021.
  • Funds reported $827M of Revance Therapeutics, Inc. stock for Q4 2021, down 44% quarter-over-quarter.
  • 34 funds opened new Revance Therapeutics, Inc. positions in Q4 2021 and 37 closed out, a net change of -3 holders.
  • The largest Revance Therapeutics, Inc. buyer in Q4 2021 was JP Morgan Chase, an estimated $30.7M added.
  • The largest Revance Therapeutics, Inc. seller in Q4 2021 was ArrowMark Colorado Holdings, an estimated $78.2M sold.

Based on aggregated 13F filings for Q4 2021.